Leidos (NYSE: LDOS) has been awarded a potential five-year, $170 million contract to help the Defense Threat Reduction AgencyÂ conduct outreach, research and training efforts as part ofÂ DTRA’sÂ cooperativeÂ biological engagementÂ and threat reduction programs.
The company said Wednesday it will support both programs through the Scientific & Technical Engagement PartnershipÂ and collaborate withÂ other companies, non-governmental organizations, research institutions and scientists to createÂ collaborative research programs abroad.
Leidos and its collaboratorsÂ will alsoÂ offer specialized training services in the areas ofÂ laboratory research, containment facilities engineering, emergency response, disease outbreak field surveillance and response andÂ public health preparedness under the contract.
“The international assistance provided under this contract will strengthen U.S. government international outreach in countering threats posed by weapons of mass destruction, particularly biological weapons,” said Tim Reardon, president of Leidos’ defense and intelligence business.
Reardon added that outreach, training and research initiativesÂ will work to help U.S. and its alliesÂ counter chemical, biological, radiological, nuclear and explosive threats worldwide.
The single-award contract containsÂ one base year andÂ four option years.
Leidos said it will perform workÂ primarily in Northern Virginia and internationally in various combatant command areas of responsibility.